Which is massages given in this blog it's just our opinion trading is ur own risk we are not responsible for profit & loss
Friday, 24 March 2017
sunpharma news
Sun Pharmaceutical Industries Ltd SUN.NS
* Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall.
* Tildrakizumab is an investigational IL-23P19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis.
* Filing includes efficacy, safety data from pivotal phase III clinical trials that included over 1,800 patients Source text - Further company coverage: SUN.NS
Followers
-
At Chandausi market , Mentha Oil is trading lower at Rs. 1025 per Kg, lower by 0.49 per cent from previous trading day. Mentha DMO is offere...
-
MUMBAI, AUG 4 --------------------------------------------------------------------------- SPOT 1-YR FWD 1-...
-
J-34 Cotton Physical Market Trading with a Firm At Abohor market , Cotton J-34(New Crop) is trading high at Rs. 3320 per Maund, higher by 0....